Advertisement
Employee use of a price transparency tool does not cut health care spending

Price Transparency Tool Doesn’t Cut Health Care Spending

0
Small percentage of eligible employees used the tool when offered
Behavior modification therapy is preferable to medication for treating children 2 to 5 years old who have attention-deficit/hyperactivity disorder

CDC: Behavioral Therapy Recommended First for ADHD

0
Parents of young children with ADHD can help them improve through guidance
Physician leaders with good leadership qualities are more likely to have employees who are satisfied and do not show signs of burnout

Physician Leadership Training May Help Counteract Burnout

0
Leadership ratings strongly linked to employee burnout and satisfaction
European residents have access to the same health care services as U.S. residents but pay much less

Report: Why Health Care Costs Are Lower in Europe Than U.S.

0
Main reason for price difference is national system that negotiates with medical providers
High school football players are more likely to suffer more symptoms after a concussion

High School Football Players Have Most Post-Concussion Symptoms

0
Meanwhile, youth league players most likely to return to field less than 24 hours after head injury

April 2016 Briefing – Neurology

0
Here are what the editors at HealthDay consider to be the most important developments in Neurology for April 2016. This roundup includes the latest...
Glaucoma may be associated with lower fractional anisotropy in the optic radiations

Glaucoma May Result From White Matter Degeneration

0
Link between glaucoma and fractional anisotropy seen in brain regions
With the nation's largest health insurer exiting all but a few Affordable Care Act exchanges next year

2017 May Offer Fewer Choices for Affordable Care Act Enrollees

0
UnitedHealth's exit from most marketplaces highlights health exchanges' growing pains
Nuplazid (pimavanserin) has been approved by the U.S. Food and Drug Administration to treat hallucinations and delusions associated with Parkinson's disease.

FDA Approves Nuplazid for Parkinson’s Hallucinations

0
Half of patients with Parkinson's may experience hallucinations, delusions
Mandatory safety training for doctors who prescribe opioids is being reconsidered by the U.S. Food and Drug Administration.

FDA Reconsidering Training for Doctors Prescribing Opioids

0
Next week, FDA committee of outside experts will meet to review risk-management plans